Loading stock data...

Zenlabs Ethica Limited

BSE: ZENLABS

BSE
30.89 0.43 (1.41%)

Prev Close

30.46

Open Price

33.24

Volume

1,218

Today Low / High

30 / 33.24

52 WK Low / High

27.33 / 44.29

Range

29 - 32

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 30.89, reflecting a change of 0.43 (1.41169%). The expected target range on the BSE is 29 - 32. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

08 Oct 33.24 -7.07%
07 Oct 31.33 -2.78%
06 Oct 33.00 -6.91%
03 Oct 32.80 -4.94%
01 Oct 32.00 -1.78%
30 Sep 32.50 -9.14%
29 Sep 30.66 2.28%
26 Sep 31.70 -3.34%
25 Sep 31.70 0.00%
24 Sep 33.09 -1.57%
23 Sep 33.90 -2.51%
22 Sep 35.00 -9.40%
19 Sep 34.93 -7.21%
18 Sep 32.00 -2.34%
17 Sep 32.40 -1.23%
16 Sep 31.26 1.57%
15 Sep 32.90 -3.16%
12 Sep 32.00 -0.53%
11 Sep 33.60 -1.82%
10 Sep 34.40 -4.07%

Zenlabs Ethica Limited Graph

Zenlabs Ethica Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Zenlabs Ethica Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 30.89, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 30.89 31.20 28.08 - 34.32
31.51 25.21 - 37.81
31.82 22.27 - 41.36
Bearish Scenario 30.89 30.58 27.52 - 33.64
30.27 24.22 - 36.33
29.96 20.97 - 38.95

Overview of Zenlabs Ethica Limited

ISIN

INE546F01013

Industry

Medical - Pharmaceuticals

Vol.Avg

5,718

Market Cap

201,094,363

Last Dividend

0

Official Website

Visit Website

IPO Date

2000-04-10

DCF Diff

-28.10

DCF

59

Financial Ratios Every Investor Needs

Stock Dividend of ZENLABS

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2022-07-29 July 29, 22 0.25 0.25 2022-08-01 2022-08-18
2017-09-20 September 20, 17 0.2381 0.25 2017-09-22 2017-10-27

Stock Rating Details for ZENLABS

Metric Value Recommendation
Overall Rating C+ Sell
DCF Score 5 Strong Buy
ROE Score 2 Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 3 Neutral

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 51.42 Cr 37.22 Cr 14.20 Cr 0.2762 0.00 Cr 4.20 Cr 1.31 Cr 0.27 Cr 0.41 2.62 Cr 0.0052
2024-03-31 58.56 Cr 43.79 Cr 14.78 Cr 0.2523 0.00 Cr 0.20 Cr 1.12 Cr 0.42 Cr 0.65 2.68 Cr 0.0072
2023-03-31 66.89 Cr 53.30 Cr 13.58 Cr 0.2031 0.00 Cr 0.23 Cr 1.78 Cr 0.49 Cr 0.75 2.46 Cr 0.0073
2022-03-31 69.09 Cr 56.39 Cr 12.69 Cr 0.1837 0.00 Cr 0.29 Cr 7.94 Cr 0.78 Cr 1.20 2.48 Cr 0.0113
2021-03-31 56.64 Cr 46.73 Cr 9.91 Cr 0.1750 0.03 Cr 0.28 Cr 5.68 Cr 0.77 Cr 1.18 1.86 Cr 0.0135

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 1.79 Cr 40.62 Cr 30.20 Cr 10.4250 Cr 12.70 Cr 10.92 Cr 13.10 Cr 2.29 Cr 0.00 Cr 0.00 Cr 0.70 Cr 28.1227 Cr
2024-03-31 0.91 Cr 40.26 Cr 30.14 Cr 10.1230 Cr 14.86 Cr 13.95 Cr 12.00 Cr 3.70 Cr 0.00 Cr 0.00 Cr 0.70 Cr 27.0212 Cr
2023-03-31 0.05 Cr 43.49 Cr 33.79 Cr 9.7035 Cr 5.84 Cr 5.79 Cr 11.37 Cr 5.02 Cr 0.00 Cr 0.00 Cr 0.39 Cr 29.4518 Cr
2022-03-31 0.01 Cr 37.90 Cr 28.57 Cr 9.3341 Cr 3.90 Cr 3.89 Cr 8.66 Cr 3.53 Cr 0.00 Cr 0.00 Cr 0.63 Cr 25.2037 Cr
2021-03-31 0.09 Cr 32.20 Cr 23.64 Cr 8.5642 Cr 2.60 Cr 2.51 Cr 5.18 Cr 3.51 Cr 0.00 Cr 0.00 Cr 0.58 Cr 21.4528 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 3.8313 Cr 0.1350 Cr -3.0846 Cr 3.8137 Cr 0.8817 Cr 1.7867 Cr -0.0176 Cr 0.4279 Cr -1.1138 Cr 0.0000 Cr -1.1039 Cr
2024-03-31 -9.0605 Cr 0.1090 Cr 8.2383 Cr -9.0826 Cr -0.7132 Cr 0.9050 Cr -0.0221 Cr 0.4212 Cr 10.0223 Cr 0.0000 Cr -0.6264 Cr
2023-03-31 1.5199 Cr -1.4681 Cr 0.0603 Cr -0.0264 Cr 0.1121 Cr 1.6182 Cr -1.5463 Cr 0.4893 Cr 1.6057 Cr -0.1628 Cr -2.7135 Cr
2022-03-31 -0.3820 Cr 0.0015 Cr 0.3131 Cr -0.4092 Cr -0.0674 Cr 1.5059 Cr -0.0272 Cr 1.2211 Cr 1.1126 Cr 0.0000 Cr -3.4702 Cr
2021-03-31 -8.4113 Cr 0.1541 Cr -0.5236 Cr -8.4129 Cr -8.7808 Cr 1.5733 Cr -0.0016 Cr 0.8600 Cr -0.4863 Cr 0.0000 Cr -0.5799 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 11.48 Cr 8.29 Cr 3.18 Cr 0.2775 0.25 Cr 0.03 Cr 0.05 0.55 Cr 0.0029
2025-03-31 12.99 Cr 8.70 Cr 4.28 Cr 0.3299 0.34 Cr 0.09 Cr 0.14 0.70 Cr 0.0070
2024-12-31 12.72 Cr 9.40 Cr 3.32 Cr 0.2613 0.36 Cr 0.09 Cr 0.13 0.68 Cr 0.0067
2024-09-30 13.35 Cr 10.08 Cr 3.27 Cr 0.2453 0.30 Cr 0.05 Cr 0.08 0.62 Cr 0.0039
2024-06-30 12.36 Cr 9.04 Cr 3.32 Cr 0.2684 0.30 Cr 0.04 Cr 0.06 0.62 Cr 0.0034

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-06-30 0.00 Cr 0.00 Cr 1.80 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -10.43 Cr
2025-03-31 1.79 Cr 0.23 Cr 2.02 Cr 19.54 Cr 13.10 Cr 37.35 Cr 2.29 Cr 40.62 Cr 30.20 Cr
2024-12-31 0.00 Cr 0.00 Cr 1.42 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -10.26 Cr
2024-09-30 1.40 Cr 0.24 Cr 1.64 Cr 19.06 Cr 14.00 Cr 36.57 Cr 2.90 Cr 40.47 Cr 30.20 Cr
2024-06-30 0.00 Cr 0.00 Cr 0.93 Cr 0.00 Cr 0.00 Cr 0.93 Cr 0.00 Cr 0.00 Cr -10.12 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 0.03 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 0.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 0.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.05 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.04 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2018-10-11 October 11, 18 21:20

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹760.95 ₹91,118,966,232.00 ₹48,228.00

Key Executives

Chief Financial Officer
Mr. Adarsh Sharma

Gender: male

Year Born:

Company Secretary & Compliance Officer
Ms. Manju Bala

Gender: female

Year Born:

Whole Time Director
Mr. Sanjay Dhir

Gender: male

Year Born: 1971

Chairman of the Board, Chief Executive Officer & MD
Mr. Sanjeev Kumar Singal

Gender: male

Year Born: 1969

FAQs about Zenlabs Ethica Limited

Who is the CEO of the company?

The CEO is Sanjeev Kumar Singal.

What is the current market price of the stock?

The current price is ₹30.89.

What is the 52-week price range?

The range is ₹27.33-44.29.

What is the market capitalization of the company?

The market capitalization is ₹20.11 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 78.91.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Zenlabs Ethica Limited (ISIN: INE546F01013) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹20.11 crores and an average daily volume of 5,718 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.